{"content":"<li class=\"n-box-item date-title\" data-end=\"1528862399\" data-start=\"1528776000\" data-txt=\"Monday, December 23, 2019\">Tuesday, June 12, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3363488\" data-ts=\"1528845860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363488-jefferies-and-t-decision-doesnt-make-sprint-t-mobile-road-easier\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies: AT&amp;T decision doesn&#39;t make Sprint/T-Mobile road any easier</a></h4><ul>   <li>Sprint and T-Mobile are among the <a href=\"https://seekingalpha.com/news/3363481-aftermarket-trade-ripples-run-wide-and-t-time-warner-decision\" target=\"_blank\">wide number of stocks moving after hours</a> in response to AT&amp;T's <a href=\"https://seekingalpha.com/news/3363456-t-prevails-time-warner-merger-trial-without-conditions\" target=\"_blank\">smackdown of the Justice Dept.</a>, on hopes that they'll benefit from a tide favoring communications/media mergers.</li>    <li>Not so fast, Jefferies says of a <a href=\"http://fingfx.thomsonreuters.com/gfx/reuterscom/1/68/68/ATTopinion.pdf\" target=\"_blank\">judicial opinion</a> that seemed more focused on the weakness of the DOJ's case than on the philosophical/antitrust merits of the combination overall.</li>    <li>The proposed Sprint/T-Mobile merger presents \"significantly higher\" antitrust concerns, analyst Scott Goldman writes: \"We do not anticipate the DOJ to be swayed by its loss in the AT&amp;T litigation.\" But T-Mobile is still a top pick, attractively valued with or without the deal, he says. (h/t Bloomberg)</li>    <li>Meanwhile, Sprint is a Hold rather than Buy, he writes.</li>    <li>Currently: <a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='green'>+2.8%</font>; <a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color='green'>+1.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363488\" data-linked=\"Jefferies: AT&amp;T decision doesn&#39;t make Sprint/T-Mobile road any easier\" data-tweet=\"$S $S $TMUS - Jefferies: AT&amp;T decision doesn&#39;t make Sprint/T-Mobile road any easier https://seekingalpha.com/news/3363488-jefferies-and-t-decision-doesnt-make-sprint-t-mobile-road-easier?source=tweet\" data-url=\"https://seekingalpha.com/news/3363488-jefferies-and-t-decision-doesnt-make-sprint-t-mobile-road-easier\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363484\" data-ts=\"1528842532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMG\" target=\"_blank\">SMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363484-scotts-miracle-gro-lawn-and-garden-purchases-hit-record-565m-in-may\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scotts Miracle-Gro lawn and garden purchases hit record $565M in May</a></h4><ul>     <li>Scotts Miracle-Gro (NYSE:<a href='https://seekingalpha.com/symbol/SMG' title='The Scotts Miracle-Gro Company'>SMG</a>) <font color='green'>+1.5%</font> after-hours as it reports consumer purchases of its lawn and garden products <a href=\"https://seekingalpha.com/pr/17190280-scottsmiracle-gro-announces-record-consumer-purchase-activity-may-updates-financial-outlook\" target=\"_blank\">surged 28% to a record $565M</a> in May, resulting in the near full recovery of the decline reported through the first seven months of FY 2018.</li>     <li>SMG says YTD purchases in the U.S. consumer segment are now nearly flat from 2017 with positive growth in lawn fertilizer, grass seed, growing media and mulch.</li>     <li>SMG now expects to report full-year sales in a range of flat to 2% higher Y/Y compared with a previous range of 2%-4% growth, assuming a 1%-3% decline in U.S. consumer sales vs. a previous projection of flat to 2% growth; sales in the Hawthorne segment are expected to rise 25%-30%, driven by the recently completed Sunlight Supply acquisition.</li>     <li>SMG sees non-GAAP adjusted EPS of $3.70-$3.90, including dilution of $0.30-$0.40 associated with the Sunlight transaction, vs. $3.96 consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363484\" data-linked=\"Scotts Miracle-Gro lawn and garden purchases hit record $565M in May\" data-tweet=\"$SMG - Scotts Miracle-Gro lawn and garden purchases hit record $565M in May https://seekingalpha.com/news/3363484-scotts-miracle-gro-lawn-and-garden-purchases-hit-record-565m-in-may?source=tweet\" data-url=\"https://seekingalpha.com/news/3363484-scotts-miracle-gro-lawn-and-garden-purchases-hit-record-565m-in-may\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363483\" data-ts=\"1528841184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERJ\" target=\"_blank\">ERJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363483-bloomberg-embraer-boeing-deal-talks-in-final-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Embraer, Boeing deal talks in final stage</a></h4><ul>     <li>Embraer (NYSE:<a href='https://seekingalpha.com/symbol/ERJ' title='Embraer S.A.'>ERJ</a>) <font color='green'>+2.4%</font> after-hours following a 5.9% spike into today's close after Brazil's Pres. Temer <a href=\"https://www.bloomberg.com/news/articles/2018-06-12/embraer-jumps-with-boeing-deal-talks-said-to-be-in-final-stage\" target=\"_blank\">endorsed in principle</a> Boeing&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>) proposed commercial jet venture with the company, according to a Bloomberg report.</li>     <li>Temer reportedly gave his blessing after Brazil&rsquo;s Air Force, defense minister and secretary of strategic affairs approved the deal; his approval would be a crucial step since the Brazilian government has veto power over any ERJ tie-up.</li>     <li>Negotiators for BA and ERJ have reached agreement on most issues and are now discussing some remaining details that amount to ~10% of the terms, Bloomberg reports.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363483\" data-linked=\"Bloomberg: Embraer, Boeing deal talks in final stage\" data-tweet=\"$ERJ $ERJ $BA - Bloomberg: Embraer, Boeing deal talks in final stage https://seekingalpha.com/news/3363483-bloomberg-embraer-boeing-deal-talks-in-final-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3363483-bloomberg-embraer-boeing-deal-talks-in-final-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363481\" data-ts=\"1528840476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363481-aftermarket-trade-ripples-run-wide-from-and-t-time-warner-decision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aftermarket trade ripples run wide from AT&amp;T/Time Warner decision</a></h4><ul>   <li>What's going on in aftermarket for stocks of other companies linked to large M&amp;A deals after AT&amp;T's (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) <a href=\"https://seekingalpha.com/news/3363456-t-prevails-time-warner-merger-trial-without-conditions\" target=\"_blank\">decisive victory over the government</a> in its pursuit of Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>)?</li>    <li>Along with mergers in <a href=\"https://seekingalpha.com/news/3363466-mega-merger-healthcare-players-positive-court-ruling-and-t-time-warner-tie\" target=\"_blank\">other sectors like healthcare</a>, most eyes are on media deals that are closer to the action. Comcast is likely to launch a formal competing cash bid of around $60B for the media assets of Twenty-First Century Fox as soon as tomorrow, setting up a wrestling match with Disney for the prized content. After hours: <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='red'>-4%</font>; <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+6.5%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+6.9%</font>; <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='red'>-1.5%</font>.</li>    <li>Comcast also is in pursuit of Sky (<a href='https://seekingalpha.com/symbol/SKYAY' title='Sky Plc ADR'>OTCPK:SKYAY</a>), also being sought by part-owner Fox as well as Disney (depending on how/when Disney's deal for Fox shakes out).</li>    <li>Sprint and T-Mobile are likely celebrating, since a rejection of the vertical combo of AT&amp;T/Time Warner would have put a massive chill on their proposed horizontal tie-up. After hours: <a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='green'>+3.4%</font>, <a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color='green'>+1.6%</font>.</li>    <li>CBS -- currently locked in an internal struggle over directives to look at re-merging with Viacom -- could re-evaluate its position, as could Viacom. In late trading, <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> <font color='green'>+4.6%</font>; <a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+5.1%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='green'>+4.3%</font>.</li>    <li>Lions Gate Entertainment is seen as a likely merger partner with ... someone, as one of a dwindling number of content firms in the medium-sized space; <a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='green'>+7.6%</font>; <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='green'>+9.5%</font>.</li>    <li>Discovery (NASDAQ:<a href='https://seekingalpha.com/symbol/DISCA' title='Discovery Inc A'>DISCA</a>), another likely merger candidate, is <font color='green'>up 3.7%</font> in late trading.</li>    <li>Sinclair Broadcast Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SBGI' title='Sinclair Broadcast Group, Inc.'>SBGI</a>) and Tribune Media (NYSE:<a href='https://seekingalpha.com/symbol/TRCO' title='Tribune Media Company'>TRCO</a>) will press for government approval of their merger, which had previously run afoul of broadcast station ownership concentration rules. <a href='https://seekingalpha.com/symbol/SBGI' title='Sinclair Broadcast Group, Inc.'>SBGI</a> <font color='green'>+1.5%</font>; <a href='https://seekingalpha.com/symbol/TRCO' title='Tribune Media Company'>TRCO</a> <font color='green'>+1.4%</font>.</li>    <li>And Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>), potentially facing a new streaming world with other companies marshaling resources to fight its dominance, is <font color='red'>off 0.9%</font> postmarket.</li>    <li>Currently after hours, with some arbitrage going on: <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-2.3%</font>; <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a> <font color='green'>+4.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363481\" data-linked=\"Aftermarket trade ripples run wide from AT&amp;T/Time Warner decision\" data-tweet=\"$T $T $TWX - Aftermarket trade ripples run wide from AT&amp;T/Time Warner decision https://seekingalpha.com/news/3363481-aftermarket-trade-ripples-run-wide-from-and-t-time-warner-decision?source=tweet\" data-url=\"https://seekingalpha.com/news/3363481-aftermarket-trade-ripples-run-wide-from-and-t-time-warner-decision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>166&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363479\" data-ts=\"1528839701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPS\" target=\"_blank\">APPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363479-digital-turbineminus-5_3-heavy-revenue-growth-still-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Turbine -5.3% as heavy revenue growth still disappoints</a></h4><ul>   <li>Digital Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a>) is <font color='red'>5.3% lower</font> after hours following <a href=\"https://seekingalpha.com/news/3363439-digital-turbine-beats-0_02-misses-revenue\" target=\"_blank\">fiscal Q4 results</a> where revenues missed despite an 80% Y/Y move.</li>    <li>The company's listed its Content and Advertisers &amp; Publishers businesses as discontinued operations after agreements to divest them.</li>    <li>Revenues grew to $21M, mainly with growth from large pre-existing carrier partners as well as some incremental contribution from new carrier/OEM partners.</li>    <li>Net loss narrowed to $4.2M from a year-ago loss of $5.8M (GAAP basis); non-GAAP net loss narrowed to $0.6M from a loss of $1.5M.</li>    <li>Adjusted EBITDA, meanwhile, was about zero vs. a year-ago loss of $0.8M.</li>    <li>Ignite installations have passed 155M total devices.</li>    <li>Cash balance came to $12.7M as of March 31, vs. $6.9M at Dec. 31.</li>    <li>It's guiding to Q1 revenue of about $23M, and positive non-GAAP adjusted EBITDA.</li>    <li><a href=\"https://seekingalpha.com/pr/17190311-digital-turbine-reports-fourth-quarter-fiscal-full-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3363479\" data-linked=\"Digital Turbine -5.3% as heavy revenue growth still disappoints\" data-tweet=\"$APPS - Digital Turbine -5.3% as heavy revenue growth still disappoints https://seekingalpha.com/news/3363479-digital-turbineminus-5_3-heavy-revenue-growth-still-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3363479-digital-turbineminus-5_3-heavy-revenue-growth-still-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363478\" data-ts=\"1528839403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363478-after-hours-gainers-losers-06-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/12/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a>&nbsp;<font color='green'>+28.5%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+6.4%</font>. <a href='https://seekingalpha.com/symbol/DISCA' title='Discovery Inc A'>DISCA</a>&nbsp;<font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color='green'>+4.9%</font>. <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>&nbsp;<font color='green'>+4.5%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a> <font color='red'>-17.2%</font>. <a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries Inc.'>OXM</a>&nbsp;<font color='red'>-6.7%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>&nbsp;<font color='red'>-3.7%.&nbsp;</font><a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a>&nbsp;<font color='red'>-3.6%</font>. <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>&nbsp;<font color='red'>-2.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363478\" data-linked=\"After Hours Gainers / Losers (06/12/2018)\" data-tweet=\"$ENPH $ENPH $FOXA - After Hours Gainers / Losers (06/12/2018) https://seekingalpha.com/news/3363478-after-hours-gainers-losers-06-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363478-after-hours-gainers-losers-06-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363470\" data-ts=\"1528837662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COMM\" target=\"_blank\">COMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363470-commscope-reaffirms-q2-fy-guidance-ahead-of-tomorrows-investor-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommScope reaffirms Q2, FY guidance ahead of tomorrow&#39;s investor day</a></h4><ul><li>        CommScope (NASDAQ:<a href='https://seekingalpha.com/symbol/COMM' title='CommScope Holding Company Inc.'>COMM</a>) <a href=\"https://seekingalpha.com/pr/17190361-commscope-provide-financial-operational-update-investor-day-tomorrow\" target=\"_blank\">reaffirms</a> its Q2 and FY18 guidance ahead of the investor day event tomorrow.</li><li>               Q2 expects revenue of $1.21B to $1.26B and EPS of $0.63 to $0.68. Non-GAAP operating income is from $230M to $250M and the adjusted effective tax rate from 29% to 30%.&nbsp;</li><li>               FY18 guidance has $4.675B to $4.825B and EPS from $2.33 to $2.48. Non-GAAP adjusted operating income is from $870M to $920M and effective tax rate from 29% to 30%. Cash flow from operations expected under $550M.&nbsp;</li><li>               The investor day event starts tomorrow at 9:30 AM Eastern with a webcast available <a href=\"http://ir.commscope.com/events-and-presentations\" target=\"_blank\">here</a>.&nbsp;</li><li>               CommScope shares are flat aftermarket at $30.24.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3363470\" data-linked=\"CommScope reaffirms Q2, FY guidance ahead of tomorrow&#39;s investor day\" data-tweet=\"$COMM - CommScope reaffirms Q2, FY guidance ahead of tomorrow&#39;s investor day https://seekingalpha.com/news/3363470-commscope-reaffirms-q2-fy-guidance-ahead-of-tomorrows-investor-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3363470-commscope-reaffirms-q2-fy-guidance-ahead-of-tomorrows-investor-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363466\" data-ts=\"1528837437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363466-mega-merger-healthcare-players-up-on-positive-court-ruling-for-and-t-time-warner-tie-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mega-merger healthcare players up on positive court ruling for AT&amp;T/Time Warner tie-up</a></h4><ul><li>Would-be merger partners CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) and Aetna (NYSE:<a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a>), up&nbsp;<font color='green'>2%</font>&nbsp;and&nbsp;<font color='green'>3%</font>, respectively, after hours, and Cigna (NYSE:<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>) and Express Scripts (NASDAQ:<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a>), up&nbsp;<font color='green'>1</font><font color='green'>%&nbsp;</font>and&nbsp;<font color='green'>5%</font>, respectively, after hours, perk up in response to the <a href=\"https://www.cnbc.com/2018/06/12/att-time-warner-ruling.html\" target=\"_blank\">news </a>that a federal judge has signed off on the legality of the $85.4B merger between AT&amp;T and Time Warner. Not only that, Judge Richard Leon did not impose any conditions on the marriage.</li><li>Last year, the U.S. Justice Department sued to block the deal for anti-competitive reasons.</li><li>The development bodes well for the two giant healthcare mergers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363466\" data-linked=\"Mega-merger healthcare players up on positive court ruling for AT&amp;T/Time Warner tie-up\" data-tweet=\"$CVS $CVS $AET - Mega-merger healthcare players up on positive court ruling for AT&amp;T/Time Warner tie-up https://seekingalpha.com/news/3363466-mega-merger-healthcare-players-up-on-positive-court-ruling-for-and-t-time-warner-tie-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3363466-mega-merger-healthcare-players-up-on-positive-court-ruling-for-and-t-time-warner-tie-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363462\" data-ts=\"1528837174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363462-t-win-combines-tremendous-reach-vast-twx-content\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T win combines tremendous reach with vast TWX content</a></h4><ul>   <li>AT&amp;T has won a <a href=\"https://seekingalpha.com/news/3363456-t-prevails-time-warner-merger-trial-without-conditions\" target=\"_blank\">stunning victory</a> in its multibillion-dollar effort to create a content/distribution juggernaut, and combines the country's top multichannel video service provider with a content empire ranging from the prestige dramas of HBO through the Warner Bros. film studio and TV channels including TBS and CNN.</li>    <li>The decision came about 19 minutes ago, and AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) is now <font color='red'>down 1.8%</font> after hours. Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>) is <font color='green'>up 5%</font>, quoting to $101.</li>    <li>The verdict is a blow to DOJ antitrust chief Makan Delrahim, who signaled a new approach to deal enforcement with his challenge to the merger in November.</li>    <li>In reaction, Delrahim says he's <a href=\"https://twitter.com/CNBCnow/status/1006640597275471875\" target=\"_blank\">disappointed with the decision</a>, and that it makes a less competitive pay TV market, but that he'll stick to his mission to protect consumers. He'll review the decision before announcing any next steps.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363462\" data-linked=\"AT&amp;T win combines tremendous reach with vast TWX content\" data-tweet=\"$T $T $TWX - AT&amp;T win combines tremendous reach with vast TWX content https://seekingalpha.com/news/3363462-t-win-combines-tremendous-reach-vast-twx-content?source=tweet\" data-url=\"https://seekingalpha.com/news/3363462-t-win-combines-tremendous-reach-vast-twx-content\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363459\" data-ts=\"1528836496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363459-vtv-therapeutics-azeliragon-flunks-late-stage-alzheimers-study-shares-halted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vtv Therapeutics&#39; azeliragon flunks late-stage Alzheimer&#39;s study; shares halted</a></h4><ul><li>Nano cap vTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a>) is set for a significant down move on the news that Part B of its Phase 3 STEADFAST study assessing azeliragon in people with mild Alzheimer's disease <a href=\"https://seekingalpha.com/pr/17190337-vtv-therapeutics-announces-topline-results-part-b-phase-3-steadfast-study\" target=\"_blank\">failed to achieve</a> the co-primary endpoints. Specifically, scores on two metrics, ADAS-cog and CDR-sb, did not separate sufficiently from placebo in participants with maximal azeliragon plasma concentrations of less than 7.5 ng/mL.</li><li>People with lower maximal plasma concentrations of azeliragon in Part B did show improvements in efficacy versus placebo based on an analysis of pooled data from Parts A and B and comparing the change from baseline at month 12.</li><li>The company says it plans to discuss the data with the FDA aimed at clarifying an accelerated approval pathway.</li><li>Shares will resume trading at 5:00 pm ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363459\" data-linked=\"Vtv Therapeutics&#39; azeliragon flunks late-stage Alzheimer&#39;s study; shares halted\" data-tweet=\"$VTVT - Vtv Therapeutics&#39; azeliragon flunks late-stage Alzheimer&#39;s study; shares halted https://seekingalpha.com/news/3363459-vtv-therapeutics-azeliragon-flunks-late-stage-alzheimers-study-shares-halted?source=tweet\" data-url=\"https://seekingalpha.com/news/3363459-vtv-therapeutics-azeliragon-flunks-late-stage-alzheimers-study-shares-halted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363456\" data-ts=\"1528836045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363456-t-prevails-in-time-warner-merger-trial-without-conditions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T prevails in Time Warner merger trial, without conditions</a></h4><ul>  <li>Judge Richard Leon has found for AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) in the telecom giant's landmark trial over an $80B-plus buyout of Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>), allowing the blockbuster deal to proceed without remedies.</li>    <li>The decision also signals a likely green light for more and faster media consolidation, most notably potential competing bids for the media assets of Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) from Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) and Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>), and bids for European broadcaster Sky (<a href='https://seekingalpha.com/symbol/SKYAY' title='Sky Plc ADR'>OTCPK:SKYAY</a>) from some permutation of Disney, Fox and Comcast.</li>    <li>AT&amp;T had previously indicated that with the lengthy time involved in the deal, it was prepared to close quickly if it got a clear go-ahead in this case, so we expect to hear details very quickly.</li><li><strong>Updated:</strong> Judge Leon has also said he would deny a stay on the deal if requested by the Justice Dept., meaning that even if DOJ appeals, the companies are free to close. That could discourage an appeal entirely.</li> <li>Time Warner is <font color='green'>up 3.9%</font> after hours; AT&amp;T <font color='red'>down 1.2%</font>.</li><li><strong>Updated 4:45 p.m.:</strong>&nbsp; <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> is <font color='green'>up 4.8%</font>&nbsp;after hours; <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> is <font color='red'>down 4%</font>&nbsp;postmarket.</li><li><strong>Updated 5:57 p.m.</strong>:&nbsp;<a href=\"http://fingfx.thomsonreuters.com/gfx/reuterscom/1/68/68/ATTopinion.pdf?utm_source=twitter&amp;utm_medium=Social\" target=\"_blank\">Read the 172-page opinion</a> in <em>United States v. AT&amp;T et al.</em></li>   &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3363456\" data-linked=\"AT&amp;T prevails in Time Warner merger trial, without conditions\" data-tweet=\"$T $T $TWX - AT&amp;T prevails in Time Warner merger trial, without conditions https://seekingalpha.com/news/3363456-t-prevails-in-time-warner-merger-trial-without-conditions?source=tweet\" data-url=\"https://seekingalpha.com/news/3363456-t-prevails-in-time-warner-merger-trial-without-conditions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>250&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363450\" data-ts=\"1528835551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363450-oral-hearing-june-26-for-puma-bios-request-for-relook-rejected-neratinib-application-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oral hearing June 26 for Puma Bio&#39;s request for relook at rejected neratinib application; shares up 2% after hours</a></h4><ul><li>The European Medicines Agency's advisory group CHMP will conduct an oral hearing on June 26 during which Puma Biotechnology (NYSE:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) may <a href=\"https://www.sec.gov/Archives/edgar/data/1401667/000119312518190533/d581386d8k.htm\" target=\"_blank\">present </a>its rationale for a re-examination of its marketing application seeking approval for neratinib for HER2-positive breast cancer.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3333786-european-advisory-group-thumbs-puma-bios-nerlynx-shares-2-percent-premarket\" target=\"_blank\">European advisory group thumbs down on Puma Bio's Nerlynx; shares down 2% premarket</a> (Feb. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363450\" data-linked=\"Oral hearing June 26 for Puma Bio&#39;s request for relook at rejected neratinib application; shares up 2% after hours\" data-tweet=\"$PBYI - Oral hearing June 26 for Puma Bio&#39;s request for relook at rejected neratinib application; shares up 2% after hours https://seekingalpha.com/news/3363450-oral-hearing-june-26-for-puma-bios-request-for-relook-rejected-neratinib-application-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3363450-oral-hearing-june-26-for-puma-bios-request-for-relook-rejected-neratinib-application-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363446\" data-ts=\"1528835340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVTL\" target=\"_blank\">PVTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363446-pivotal-softwareplus-5_4-on-q1-beats-upside-fy-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pivotal Software +5.4% on Q1 beats, upside FY guidance</a></h4><ul><li>        Pivotal Software (NYSE:<a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software'>PVTL</a>) shares are&nbsp;<font color='green'>up 5.4%</font>&nbsp;aftermarket on the first earnings report since the IPO. Q1 results beat EPS and revenue estimates with a 29% Y/Y revenue growth. Q2 guidance has revenue from $157M to $159M (consensus: $152.81M) and EPS from -$0.10 to -$0.09 (consensus: -$0.10).</li><li>               Upside FY19 guidance has revenue from $642M to $649M (consensus: $622.03M) and EPS from -$0.39 to -$0.37 (consensus: -$0.45).&nbsp;</li><li>               Earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"https://investors.pivotal.io/home/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17190296-pivotal-reports-first-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">Press release</a>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363431-pivotal-software-beats-0_03-beats-revenue\" target=\"_blank\">Pivotal Software beats by $0.03, beats on revenue</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363446\" data-linked=\"Pivotal Software +5.4% on Q1 beats, upside FY guidance\" data-tweet=\"$PVTL - Pivotal Software +5.4% on Q1 beats, upside FY guidance https://seekingalpha.com/news/3363446-pivotal-softwareplus-5_4-on-q1-beats-upside-fy-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3363446-pivotal-softwareplus-5_4-on-q1-beats-upside-fy-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363442\" data-ts=\"1528834943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSCI\" target=\"_blank\">WSCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363442-wsi-industries-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSI Industries reports Q3 results</a></h4><ul><li>WSI Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/WSCI' title='WSI Industries Inc.'>WSCI</a>): Q3 EPS of $0.16</li><li>Revenue of $9.79M (+2.1% Y/Y)</li><li>Shares <font color='green'>+16.19%</font>.</li><li><a href='https://seekingalpha.com/pr/17190314-wsi-industries-reports-improved-third-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3363442\" data-linked=\"WSI Industries reports Q3 results\" data-tweet=\"$WSCI - WSI Industries reports Q3 results https://seekingalpha.com/news/3363442-wsi-industries-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3363442-wsi-industries-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363434\" data-ts=\"1528834556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363434-enphase-energy-to-buy-sunpower-s-microinverter-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase Energy to buy SunPower\u2019s microinverter business</a></h4><ul>     <li>Enphase Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a>) <font color='green'>+16%</font> after-hours following news it has <a href=\"https://seekingalpha.com/pr/17190269-enphase-energy-acquire-sunpower-s-microinverter-business\" target=\"_blank\">agreed to acquire</a> SunPower&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a>) microinverter business for $25M in cash and 7.5M ENPH common shares.</li>     <li>The companies say the five-year agreement will accelerate global adoption of AC Modules as the de facto residential solution.</li>     <li>ENPH says it expects to add $60M-$70M in annualized revenue in H2 2019 at a 33%-35% gross margin.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363434\" data-linked=\"Enphase Energy to buy SunPower\u2019s microinverter business\" data-tweet=\"$ENPH $ENPH $SPWR - Enphase Energy to buy SunPower\u2019s microinverter business https://seekingalpha.com/news/3363434-enphase-energy-to-buy-sunpower-s-microinverter-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3363434-enphase-energy-to-buy-sunpower-s-microinverter-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363431\" data-ts=\"1528834432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVTL\" target=\"_blank\">PVTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363431-pivotal-software-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pivotal Software beats by $0.03, beats on revenue</a></h4><ul><li>Pivotal Software (NYSE:<a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software'>PVTL</a>): Q1 EPS of -$0.10 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $155.74M (+28.5% Y/Y) <font color='green'>beats by $15.3M</font>.</li><li>Shares <font color='green'>+7.45%</font>.</li><li><a href='https://seekingalpha.com/pr/17190296-pivotal-reports-first-quarter-fiscal-year-2019-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3363431\" data-linked=\"Pivotal Software beats by $0.03, beats on revenue\" data-tweet=\"$PVTL - Pivotal Software beats by $0.03, beats on revenue https://seekingalpha.com/news/3363431-pivotal-software-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3363431-pivotal-software-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363430\" data-ts=\"1528834334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363430-nutanix-closesplus-7_6-on-higher-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutanix closes +7.6% on higher volume</a></h4><ul><li>        Nutanix (NASDAQ:<a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a>) closed today&nbsp;<font color='green'>up 7.6%</font>&nbsp;to $60.65 on higher volume.</li><li>               Volume was roughly 7M compared to the 3.73M average volume.</li><li>               The company presented at the Stifel 2018 Cross Sector Insight Conference (<a href=\"http://wsw.com/webcast/stifel11/register.aspx?conf=stifel11&amp;page=ntnx&amp;url=http://wsw.com/webcast/stifel11/ntnx/index.aspx\" target=\"_blank\">webcast</a>) and Nasdaq 38th Investor Conference (<a href=\"https://edge.media-server.com/m6/p/97ffzzxi\" target=\"_blank\">webcast</a>) today. &nbsp;&nbsp;</li><li>               Nutanix shares are&nbsp;<font color='green'>up 0.2%</font>&nbsp;aftermarket to $60.74.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3363430\" data-linked=\"Nutanix closes +7.6% on higher volume\" data-tweet=\"$NTNX - Nutanix closes +7.6% on higher volume https://seekingalpha.com/news/3363430-nutanix-closesplus-7_6-on-higher-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3363430-nutanix-closesplus-7_6-on-higher-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363408\" data-ts=\"1528829745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGMH\" target=\"_blank\">AGMH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363408-technology-top-5-gainers-losers-of-2_55-pm-06-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (06/12/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/DTRM' title='Determine, Inc.'>OTC:DTRM</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LASR' title='nLIGHT, Inc.'>LASR</a> <font color='green'>+7%</font>.</li>      <li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RFIL' title='RF Industries, Ltd.'>RFIL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-8%</font>.</li>     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3363408\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (06/12/2018)\" data-tweet=\"$AGMH $AGMH $NIHD - Technology - Top 5 Gainers / Losers as of 2.55 PM (06/12/2018) https://seekingalpha.com/news/3363408-technology-top-5-gainers-losers-of-2_55-pm-06-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363408-technology-top-5-gainers-losers-of-2_55-pm-06-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363402\" data-ts=\"1528827483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLB\" target=\"_blank\">SLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363402-schlumberger-sees-10minus-15-profit-growth-in-q2-shares-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schlumberger sees 10%-15% profit growth in Q2 but shares slide</a></h4><ul>     <li>Schlumberger (<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='red'>-2.3%</font>) is lower after outlining <a href=\"https://www.reuters.com/article/schlumberger-results/brief-schlumberger-expects-2q-profits-to-grow-by-10-to-15-pct-executive-idUSL1N1TE12Y\" target=\"_blank\">expectations for 10%-15% EPS growth in Q2</a> and a 12%-13% increase in North America revenues during a <a href=\"https://www.slb.com/news/presentations/2018/2018-0612-schorn-wells-fargo.aspx\" target=\"_blank\">presentation</a> at a Wells Fargo energy conference in San Francisco.</li><li>SLB sees international revenues rising 6%-7% but with lower than expected revenue growth in the Middle East due to  delays and drilling challenges related to the start of projects in  Saudi Arabia, Iraq and India.</li><li>SLB says it is mobilizing 30 rigs internationally this quarter and  expects to mobilize an additional 25 rigs in Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363402\" data-linked=\"Schlumberger sees 10%-15% profit growth in Q2 but shares slide\" data-tweet=\"$SLB - Schlumberger sees 10%-15% profit growth in Q2 but shares slide https://seekingalpha.com/news/3363402-schlumberger-sees-10minus-15-profit-growth-in-q2-shares-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/3363402-schlumberger-sees-10minus-15-profit-growth-in-q2-shares-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363401\" data-ts=\"1528827017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363401-bloomberg-jd-com-setting-up-for-thailand-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: JD.com setting up for Thailand expansion</a></h4><ul>   <li>JD.com (<a href=\"http://seekingalpha.com/symbol/JD\" target=\"_blank\">JD</a> <font color='green'>+3.9%</font>) is building infrastructure for an expansion into Thailand in coming months, Bloomberg reports.</li>    <li>It's building fulfillment centers there and will deploy a delivery fleet in Bangkok while tapping third parties to help with deliveries in other parts of the country.</li>    <li>Most of its current 15-warehouse capacity is dedicated to importing goods into China. Some 85% of packages through its own network in Indonesia are now delivered within 24 hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363401\" data-linked=\"Bloomberg: JD.com setting up for Thailand expansion\" data-tweet=\"$JD - Bloomberg: JD.com setting up for Thailand expansion https://seekingalpha.com/news/3363401-bloomberg-jd-com-setting-up-for-thailand-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3363401-bloomberg-jd-com-setting-up-for-thailand-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363399\" data-ts=\"1528826460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363399-google-facebook-twitter-face-new-house-panel-hearing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google, Facebook, Twitter face new House panel hearing</a></h4><ul>   <li>It's back to the Hill for major tech giants.</li>    <li>The House Judiciary Committee is recalling representatives from Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.5%</font>), Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+0.9%</font>) and Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='green'>+6.3%</font>) to testify June 26 in a hearing it's planning to address anti-conservative bias, Bloomberg notes.</li>    <li>Yesterday, Facebook delivered <a href=\"https://seekingalpha.com/news/3363182-facebook-turns-450-pages-follow-answers-congress\" target=\"_blank\">450 pages of documents</a> that purported to answer questions that Mark Zuckerberg couldn't address during appearances before House and Senate panels in April.</li>    <li>It's been a spring of testimony for representatives of the companies in the wake of the Cambridge Analytica privacy scandal and growing scrutiny of how they manage user privacy and treat news dissemination.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363399\" data-linked=\"Google, Facebook, Twitter face new House panel hearing\" data-tweet=\"$GOOG $GOOG $GOOGL - Google, Facebook, Twitter face new House panel hearing https://seekingalpha.com/news/3363399-google-facebook-twitter-face-new-house-panel-hearing?source=tweet\" data-url=\"https://seekingalpha.com/news/3363399-google-facebook-twitter-face-new-house-panel-hearing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363398\" data-ts=\"1528826448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMG\" target=\"_blank\">KMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363398-energy-materials-top-5-gainers-losers-of-2-00-pm-06-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KMG' title='KMG Chemicals, Inc.'>KMG</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/DWSN' title='Dawson Geophysical Company'>DWSN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SDT' title='SandRidge Mississippian Trust I'>SDT</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363398\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/12/2018)\" data-tweet=\"$KMG $KMG $SAEX - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/12/2018) https://seekingalpha.com/news/3363398-energy-materials-top-5-gainers-losers-of-2-00-pm-06-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363398-energy-materials-top-5-gainers-losers-of-2-00-pm-06-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363391\" data-ts=\"1528823082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363391-intelsat-rebounds-6_7-after-pricing-shares-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat rebounds 6.7% after pricing shares, notes</a></h4><ul>   <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>) is <font color='green'>up 6.7%</font> in NYSE trading after <a href=\"https://seekingalpha.com/news/3363179-intelsat-prices-share-offering-convertible-note-offering\" target=\"_blank\">last night's pricing</a> of dual offerings of shares and convertible notes.</li>    <li>That's a rebound from a <font color='red'>10% decline</font> Monday.</li>    <li>Shares have been on a relatively precipitous climb in 2018, <font color='green'>up 549%</font> from a 52-week low of $2.44 in early February.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363391\" data-linked=\"Intelsat rebounds 6.7% after pricing shares, notes\" data-tweet=\"$I - Intelsat rebounds 6.7% after pricing shares, notes https://seekingalpha.com/news/3363391-intelsat-rebounds-6_7-after-pricing-shares-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3363391-intelsat-rebounds-6_7-after-pricing-shares-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363386\" data-ts=\"1528822841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIEB\" target=\"_blank\">SIEB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363386-financials-top-gainers-losers-of-1-00-pm-06-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (06/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AIHS' title='Senmiao Technology'>AIHS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/JCAP' title='Jernigan Capital'>JCAP</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363386\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (06/12/2018)\" data-tweet=\"$SIEB $SIEB $AIHS - Financials - Top Gainers / Losers as of 1:00 PM (06/12/2018) https://seekingalpha.com/news/3363386-financials-top-gainers-losers-of-1-00-pm-06-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363386-financials-top-gainers-losers-of-1-00-pm-06-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363385\" data-ts=\"1528822532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363385-tyme-technologies-smminus-88-shows-anti-tumor-effect-across-range-of-cancers-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyme Technologies&#39; SM-88 shows anti-tumor effect across range of cancers; shares up 10%</a></h4><ul><li>Thinly traded micro cap Tyme Technologies (<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a> <font color='green'>+9.6%</font>) is up on below-average volume in response to its release of <a href=\"https://seekingalpha.com/pr/17189333-tyme-releases-detailed-data-analyses-smminus-88-first-human-study-compassionate-use-programs\" target=\"_blank\">patient data</a> on lead candidate SM-88.</li><li>In 83 evaluable patients from the First Human Study and Compassionate Use Program, the objective response rates &#40;ORR&#41; were 33% and 45%, respectively, across 15 different cancer types. The ORR in breast cancer patients was 44% (n=11/25), including two of five with triple negative breast cancer.</li><li>40% (n=33/83) of patients experienced stable cancer with median overall survival of 43 months (time period: late 2011 into 2017).</li><li>The company says it remains focused on completing its ongoing clinical trials and will consider expanding development of SM-88 into additional cancers.</li><li><a href=\"https://www.tymeinc.com/sm-88/what-is-sm-88/\" target=\"_blank\">SM-88</a>&nbsp;is a combination therapy that uses a proprietary dysfunctional tyrosine derivative to interrupt the metabolic processes of cancer cells, breaking down their defenses and making them vulnerable to oxidative stress and death.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329505-tymes-lead-candidate-smminus-88-shows-treatment-effect-mid-stage-prostate-cancer-study-shares\" target=\"_blank\">Tyme's lead candidate SM-88 shows treatment effect in mid-stage prostate cancer study; shares ahead 4%</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363385\" data-linked=\"Tyme Technologies&#39; SM-88 shows anti-tumor effect across range of cancers; shares up 10%\" data-tweet=\"$TYME - Tyme Technologies&#39; SM-88 shows anti-tumor effect across range of cancers; shares up 10% https://seekingalpha.com/news/3363385-tyme-technologies-smminus-88-shows-anti-tumor-effect-across-range-of-cancers-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3363385-tyme-technologies-smminus-88-shows-anti-tumor-effect-across-range-of-cancers-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363383\" data-ts=\"1528821935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SITO\" target=\"_blank\">SITO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363383-sito-mobileminus-15-on-new-q2-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sito Mobile -15% on new Q2 revenue guidance</a></h4><ul>   <li>Sito Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a>) has <font color='red'>slid 15.2%</font> after <a href=\"https://seekingalpha.com/pr/17189458-sito-mobile-revises-expectation-second-quarter-revenue\" target=\"_blank\">revising expectations on Q2 revenues</a>.</li>    <li>It now expects revenues for the quarter ending June 30 to fall in the $8M-$9M range; that's down from Q1's $11.1M.</li>    <li>&ldquo;We continue to advance the transition of our business from more traditional media delivery services with one-time, monthly campaign revenue to high-value consumer behavior research and media placement services for large enterprise brands and key agencies in order to deliver recurring revenue over many months,\" says CEO Tom Pallack in commenting on the revision.</li>    <li>\"We are confident this transition will best position SITO for continued success over the long-term, despite the near-term challenges of revenue performance and predictability. We remain optimistic about the opportunities for growth in 2018.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363383\" data-linked=\"Sito Mobile -15% on new Q2 revenue guidance\" data-tweet=\"$SITO - Sito Mobile -15% on new Q2 revenue guidance https://seekingalpha.com/news/3363383-sito-mobileminus-15-on-new-q2-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3363383-sito-mobileminus-15-on-new-q2-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363373\" data-ts=\"1528821499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMNR\" target=\"_blank\">LMNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363373-limoneira-down-11-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limoneira down 11% post Q2 results</a></h4><ul><li>Limoneira (<a href='https://seekingalpha.com/symbol/LMNR' title='Limoneira'>LMNR</a> <font color='red'>-11.3%</font>) reported Q2 revenue growth of 17% Y/Y to $43.14M due to higher lemon sales.</li><li>Segment sales: Agribusiness $41.85M (+18.2% Y/Y) and rental operations $1.27M (-14% Y/Y).</li><li>Agribusiness revenue includes $33.6M (+28.2% Y/Y) in lemon sales, ~1.16M cartons at an average price of $23.48 per carton were sold in the quarter.</li><li>Q2 operating margin&nbsp;<font color='green'>improved by 491 bps</font>&nbsp;to 21.75% and Adj. EBITDA margin&nbsp;<font color='green'>improved by 424 bps</font>&nbsp;to 25.52%.</li><li>Q2 total cost and expenses were up by 10.1% Y/Y to $33.8M reflecting increase in agribusiness and overall costs.</li><li>FY18 Outlook: EPS $0.65-0.75; operating income $15.7-17.8M; EBITDA $23-25M and LMNR expects to sell between 3.1-3. 3M cartons of lemons at an average price of ~$24.5 per carton and ~6-6.5M pounds of avocados at ~$1.3 per pound.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363108-limoneira-beats-0_02-misses-revenue\" target=\"_blank\">Limoneira beats by $0.02, misses on revenue</a> (June 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363373\" data-linked=\"Limoneira down 11% post Q2 results\" data-tweet=\"$LMNR - Limoneira down 11% post Q2 results https://seekingalpha.com/news/3363373-limoneira-down-11-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3363373-limoneira-down-11-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363382\" data-ts=\"1528821340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLMD\" target=\"_blank\">GLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363382-midday-gainers-losers-06-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/12/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+194%</font>. <a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a> <font color='green'>+15%</font>.</li>      <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NAUH' title='National American University Holdings, Inc.'>OTC:NAUH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LMNR' title='Limoneira'>LMNR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BHTG' title='BioHiTech Global, Inc.'>BHTG</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RFIL' title='RF Industries, Ltd.'>RFIL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/GFF' title='Griffon Corporation'>GFF</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363382\" data-linked=\"Midday Gainers / Losers (06/12/2018)\" data-tweet=\"$GLMD $GLMD $RH - Midday Gainers / Losers (06/12/2018) https://seekingalpha.com/news/3363382-midday-gainers-losers-06-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363382-midday-gainers-losers-06-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363381\" data-ts=\"1528821287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363381-piper-jaffray-checks-show-strong-q2-for-irobot-sharesplus-7_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray checks show strong Q2 for iRobot; shares +7.5%</a></h4>&nbsp; <ul><li>        IRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>) shares&nbsp;<font color='green'>gain 7.5%</font>&nbsp;after Piper Jaffray<a href=\"https://www.streetinsider.com/Analyst+Comments/Piper+Jaffray+Reiterates+Overweight+on+iRobot+Corp.+%28IRBT%29/14297394.html\" target=\"_blank\"> says</a> its mid-quarter channel checks show that Q2 results appear to be ahead of expectations.</li><li>               Firm maintains an Overweight rating and $78 price target.&nbsp;</li><li>               IRobot will report Q2 results on July 24. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3363381\" data-linked=\"Piper Jaffray checks show strong Q2 for iRobot; shares +7.5%\" data-tweet=\"$IRBT - Piper Jaffray checks show strong Q2 for iRobot; shares +7.5% https://seekingalpha.com/news/3363381-piper-jaffray-checks-show-strong-q2-for-irobot-sharesplus-7_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3363381-piper-jaffray-checks-show-strong-q2-for-irobot-sharesplus-7_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363377\" data-ts=\"1528820962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363377-sears-higher-after-expanding-amazon-tire-installation-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sears higher after expanding Amazon tire installation program</a></h4><ul> <li>Sears Holdings (SHLD) is&nbsp;<font color='green'>up 8.71%</font>&nbsp;after expanding its tire partnership with Amazon.</li> <li>The company says the Amazon tire installation partnership is now in 118 stores, up from the initial 47 locations.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3363377\" data-linked=\"Sears higher after expanding Amazon tire installation program\" data-tweet=\"$SHLDQ - Sears higher after expanding Amazon tire installation program https://seekingalpha.com/news/3363377-sears-higher-after-expanding-amazon-tire-installation-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3363377-sears-higher-after-expanding-amazon-tire-installation-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363372\" data-ts=\"1528820271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENBL\" target=\"_blank\">ENBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363372-enable-midstream-upgraded-targa-and-dcp-midstream-cut-barclays\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enable Midstream upgraded, Targa and DCP Midstream cut at Barclays</a></h4><ul>     <li>Enable Midstream Partners (<a href='https://seekingalpha.com/symbol/ENBL' title='Enable Midstream Partners LP'>ENBL</a> <font color='green'>+2%</font>) is higher after Barclays <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/06/11866091/barclays-downgrades-targa-dcp-midstream-on-decelerating\" target=\"_blank\">upgrades</a> shares to Equal Weight from Underweight with a $17 price target, raised from $14, saying ENBL is poised to benefit over the coming quarters from a shifting U.S. production outlook.</li>     <li>Anadarko Petroleum's positive results and revised expectations for Haynesville reflect ENBL's intention to deploy capital in basins that are less hampered by infrastructure constraints than the Permian Basin, says Barclays analyst Christine Cho.</li>     <li>At the same time, Barclays downgrades Targa Resources (<a href='https://seekingalpha.com/symbol/TRGP' title='Targa Resources Corp.'>TRGP</a> <font color='red'>-1.6%</font>) to Equal Weight from Overweight with a $52 price target and DCP&nbsp;Midstream (<a href='https://seekingalpha.com/symbol/DCP' title='DCP Midstream'>DCP</a> <font color='green'>+0.1%</font>) to Underweight from Equal Weight with a $39 target.</li>     <li>Cho is optimistic on TRGP's Q2 estimates thanks to robust volumes but is concerned about Permian volumes over the next 12-18 months, and notes that DCP trades at a slight premium to the G&amp;P group average despite having no distribution growth and coverage of ~1x.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363372\" data-linked=\"Enable Midstream upgraded, Targa and DCP Midstream cut at Barclays\" data-tweet=\"$ENBL $ENBL $TRGP - Enable Midstream upgraded, Targa and DCP Midstream cut at Barclays https://seekingalpha.com/news/3363372-enable-midstream-upgraded-targa-and-dcp-midstream-cut-barclays?source=tweet\" data-url=\"https://seekingalpha.com/news/3363372-enable-midstream-upgraded-targa-and-dcp-midstream-cut-barclays\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363369\" data-ts=\"1528819287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTR\" target=\"_blank\">DLTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363369-credit-suisse-defends-dollar-tree\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse defends Dollar Tree</a></h4><ul> <li>Credit Suisse updates on Dollar Tree (<a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a> <font color='green'>+3.2%</font>) after last month's Q1 earnings report from the retailer sent shares lower.</li> <li>The analyst team thinks investors are negative over the results of the Family Dollar integration in particular.</li> <li>\"Whereas results have not been anywhere near initial expectations when the deal closed almost 3 years ago, we believe sentiment is overly negative and that risk/reward actually skews to the upside. A sum-of-the-parts valuation, recent ramp in remodel activity, and potentially opportune timing in the economic cycle lead us to reiterate our Outperform rating,\" writes analyst Judah Frommer and team.</li><li>CS says its price target of $93 on Dollar Tree is&nbsp;~15.5X its near-term EPS estimate.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3360654-dollar-tree-sheds-8-percent-weak-profit-guidance\" target=\"_blank\">Dollar Tree sheds 8% after weak profit guidance</a> (May 31)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363369\" data-linked=\"Credit Suisse defends Dollar Tree\" data-tweet=\"$DLTR - Credit Suisse defends Dollar Tree https://seekingalpha.com/news/3363369-credit-suisse-defends-dollar-tree?source=tweet\" data-url=\"https://seekingalpha.com/news/3363369-credit-suisse-defends-dollar-tree\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363368\" data-ts=\"1528819261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XENE\" target=\"_blank\">XENE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363368-xenon-pharma-continues-northward-march-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenon Pharma continues northward march, up 15%</a></h4><ul><li>Thinly traded micro cap Xenon Pharmaceuticals (<a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a> <font color='green'>+14.5%</font>) is up on almost 60% higher volume, albeit on turnover of only 220K shares, building on its extended rally. Shares have nearly tripled this year.</li><li>The company develops therapies for neurological disorders. Pipeline candidates include <a href=\"https://www.xenon-pharma.com/product-pipeline/xen1101-for-epilepsy/\" target=\"_blank\">XEN1101 </a>and <a href=\"https://www.xenon-pharma.com/product-pipeline/xen901-for-epilepsy/\" target=\"_blank\">XEN901 </a>for epilepsy, <a href=\"https://www.xenon-pharma.com/product-pipeline/xen007-for-hemiplegic-migrane/\" target=\"_blank\">XEN007 </a>for hemiplegic migraine and <a href=\"https://www.xenon-pharma.com/product-pipeline/gdc-0310-for-pain/\" target=\"_blank\">GDC-0310</a> for pain (with Genentech).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3356673-xenon-pharma-21-percent-premarket-positive-xen1101-data\" target=\"_blank\">Xenon Pharma up 21% premarket on positive XEN1101 data</a> (May 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363368\" data-linked=\"Xenon Pharma continues northward march, up 15%\" data-tweet=\"$XENE - Xenon Pharma continues northward march, up 15% https://seekingalpha.com/news/3363368-xenon-pharma-continues-northward-march-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3363368-xenon-pharma-continues-northward-march-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363367\" data-ts=\"1528819230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNDI\" target=\"_blank\">KNDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363367-consumer-top-5-gainers-losers-of-12-00-pm-06-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/HBB' title='Hamilton Beach Brands Holding Company'>HBB</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LMNR' title='Limoneira'>LMNR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation Class A'>DOGZ</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363367\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/12/2018)\" data-tweet=\"$KNDI $KNDI $IRBT - Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/12/2018) https://seekingalpha.com/news/3363367-consumer-top-5-gainers-losers-of-12-00-pm-06-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363367-consumer-top-5-gainers-losers-of-12-00-pm-06-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363363\" data-ts=\"1528818109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363363-exxon-plains-to-partner-on-permian-pipeline-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon, Plains to partner on Permian pipeline project</a></h4><ul>     <li>Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-0.4%</font>) says it plans to create a joint venture with Plains All American Pipeline (<a href='https://seekingalpha.com/symbol/PAA' title='Plains All American Pipeline, L.P.'>PAA</a> <font color='green'>+2%</font>) to <a href=\"https://www.chron.com/business/energy/article/Exxon-Mobil-Plains-partner-on-Permian-pipeline-12987234.php\" target=\"_blank\">construct a multibillion-dollar pipeline</a> to carry oil and condensate from the Permian Basin to the Texas Gulf Coast.</li>     <li>XOM earlier this year said it planned to triple its oil and gas production in the Permian by 2025 while also spending more than $2B on transportation and terminal upgrades in west Texas, including expanding its crude oil terminal in Wink; the JV pipeline  with PAA would originate in Wink.</li><li>PAA and Magellan Midstream Partners recently expanded  their BridgeTex oil pipeline, which has served as the major artery from  west Texas to the Houston region, but Permian oil production is at  a record high and the lack of pipelines has created  bottlenecks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363363\" data-linked=\"Exxon, Plains to partner on Permian pipeline project\" data-tweet=\"$XOM $XOM $PAA - Exxon, Plains to partner on Permian pipeline project https://seekingalpha.com/news/3363363-exxon-plains-to-partner-on-permian-pipeline-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3363363-exxon-plains-to-partner-on-permian-pipeline-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363362\" data-ts=\"1528817699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIN\" target=\"_blank\">DIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363362-dine-brands-rides-ihob-buzz-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dine Brands rides IHOb buzz higher</a></h4><ul> <li>Dine Brands Global (NYSE:<a href='https://seekingalpha.com/symbol/DIN' title='Dine Brands Global, Inc.'>DIN</a>) is&nbsp;<font color='green'>up 2.58%</font>&nbsp;as the company is getting some credit from investors for its IHOb marketing stunt.</li> <li>The strategy to \"temporarily\" change the name of the IHOP chain to IHOb drew the social media firestorm that was planned for ahead of the roll-out of new hamburger menu items.</li> <li>Shares of Dine Brands are up about 8% over the last week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362934-meet-ihob-b-burgers\" target=\"_blank\">Meet IHOb - the 'b' is for burgers</a> (June 11)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363362\" data-linked=\"Dine Brands rides IHOb buzz higher\" data-tweet=\"$DIN - Dine Brands rides IHOb buzz higher https://seekingalpha.com/news/3363362-dine-brands-rides-ihob-buzz-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3363362-dine-brands-rides-ihob-buzz-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363353\" data-ts=\"1528817116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLMD\" target=\"_blank\">GLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363353-nash-players-perk-up-on-galmed-surge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nash players perk up on Galmed surge</a></h4><ul><li>Money flow has perked up in certain NASH players after Galmed Pharmaceuticals (<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+183.4%</font>) reported positive results on Aramchol this morning.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+5%</font>)(<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='green'>+5.1%</font>)(<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+3.3%</font>)(<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='red'>-2.6%</font>)(<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+2.5%</font>)(<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='red'>-0.2%</font>)(<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='green'>+1.7%</font>)(<a href='https://seekingalpha.com/symbol/GNFTF' title='Genfit'>OTCPK:GNFTF</a> <font color='green'>+1.9%</font>)(<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='green'>+2.9%</font>)(<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='red'>-3.6%</font>)(<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a>)(<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color='green'>+5.1%</font>)(<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='red'>-1.2%</font>)(<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-5.1%</font>)(TKPYY <font color='green'>+1.5%)</font>(<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+20.1%</font>)(<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Ltd.'>ARCT</a> <font color='red'>-2.5%</font>)(<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen'>FGEN</a> <font color='green'>+1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363226-galmed-release-mid-stage-data-nash-candidate-aramchol-morning-shares-60-percent-premarket\" target=\"_blank\">Galmed to release mid-stage data on NASH candidate Aramchol this morning; shares up 60% premarket</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363353\" data-linked=\"Nash players perk up on Galmed surge\" data-tweet=\"$GLMD $GLMD $CBAY - Nash players perk up on Galmed surge https://seekingalpha.com/news/3363353-nash-players-perk-up-on-galmed-surge?source=tweet\" data-url=\"https://seekingalpha.com/news/3363353-nash-players-perk-up-on-galmed-surge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363351\" data-ts=\"1528816280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSTK\" target=\"_blank\">SSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363351-shutterstockplus-1_9-on-launch-of-dublin-office\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shutterstock +1.9% on launch of Dublin office</a></h4><ul><li>        Shutterstock (NYSE:<a href='https://seekingalpha.com/symbol/SSTK' title='Shutterstock'>SSTK</a>) <a href=\"https://seekingalpha.com/pr/17189890-shutterstock-launches-ireland-office\" target=\"_blank\">announces the launch</a> of its Dublin office and initial plans to hire 40 professionals including engineers.</li><li>               Shutterstock shares are&nbsp;<font color='green'>up 1.9%</font>&nbsp;to $48.94.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3363351\" data-linked=\"Shutterstock +1.9% on launch of Dublin office\" data-tweet=\"$SSTK - Shutterstock +1.9% on launch of Dublin office https://seekingalpha.com/news/3363351-shutterstockplus-1_9-on-launch-of-dublin-office?source=tweet\" data-url=\"https://seekingalpha.com/news/3363351-shutterstockplus-1_9-on-launch-of-dublin-office\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363348\" data-ts=\"1528815937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOV\" target=\"_blank\">MOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363348-movado-falls-after-sidoti-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Movado falls after Sidoti cut</a></h4><ul> <li>Movado (<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='red'>-3.4%</font>) slides after Sidoti drops its rating on the apparel stock to Neutral from Buy on a call tied to valuation.</li> <li>The investment firm sets a price target of $57 on Movado.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3363348\" data-linked=\"Movado falls after Sidoti cut\" data-tweet=\"$MOV - Movado falls after Sidoti cut https://seekingalpha.com/news/3363348-movado-falls-after-sidoti-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3363348-movado-falls-after-sidoti-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363346\" data-ts=\"1528815900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363346-nxp-semiconductorsminus-1_8-after-senate-pushback-on-zte-ban-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NXP Semiconductors -1.8% after Senate pushback on ZTE ban lift</a></h4><ul><li>        NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>)&nbsp;<font color='red'>drops 1.8%</font>&nbsp;after the report that the U.S. Senate is prepared for a showdown with the White House over the ZTE ban lift.</li><li>               Qualcomm&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) acquisition of NXP still requires the approval of Chinese regulators and the market is reacting to any indication of easing or worsening tensions between the nations.&nbsp;</li><li>               Qualcomm shares are&nbsp;<font color='red'>down 0.1%</font>&nbsp;to $59.89. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363229-acacia-communications-plus-1_1-percent-zte-statement-reaffirmed-guidance\" target=\"_blank\">Acacia Communications +1.1% on ZTE statement, reaffirmed guidance</a> (June 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363229-acacia-communications-plus-1_1-percent-zte-statement-reaffirmed-guidance\" target=\"_blank\">Acacia Communications +1.1% on ZTE statement, reaffirmed guidance</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363346\" data-linked=\"NXP Semiconductors -1.8% after Senate pushback on ZTE ban lift\" data-tweet=\"$NXPI $NXPI $QCOM - NXP Semiconductors -1.8% after Senate pushback on ZTE ban lift https://seekingalpha.com/news/3363346-nxp-semiconductorsminus-1_8-after-senate-pushback-on-zte-ban-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3363346-nxp-semiconductorsminus-1_8-after-senate-pushback-on-zte-ban-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363341\" data-ts=\"1528815632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLMD\" target=\"_blank\">GLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363341-healthcare-top-5-gainers-losers-of-11-00-06-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+206%</font>. <a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/KDMN' title='Kadmon Holdings'>KDMN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ENZ' title='Enzo Biochem, Inc.'>ENZ</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363341\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/12/2018)\" data-tweet=\"$GLMD $GLMD $SAGE - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/12/2018) https://seekingalpha.com/news/3363341-healthcare-top-5-gainers-losers-of-11-00-06-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363341-healthcare-top-5-gainers-losers-of-11-00-06-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363339\" data-ts=\"1528815335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363339-goproplus-2_6-catching-ride-fitbit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro +2.6% catching a ride with Fitbit</a></h4><ul><li>        GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a>)&nbsp;<font color='green'>gains 2.6%</font>&nbsp;to $6.40 with no catalyst of its own.</li><li>               Stock likely hitching a ride with Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>), which is&nbsp;<font color='green'>up 2.5%&nbsp;</font>today,&nbsp;<font color='green'>24%</font>&nbsp;in the past week,&nbsp;<font color='green'>37.6%&nbsp;</font>for the month, and&nbsp;<font color='green'>27.5%</font>&nbsp;YTD. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362982-fitbit-plus-4_4-percent-launch-wearable-kids\" target=\"_blank\">Fitbit +4.4% on launch of wearable for kids</a> (June 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363040-citron-research-report-sets-fitbit-136-percent-upside-fit-plus-6_5-percent\" target=\"_blank\">Citron Research report sets Fitbit at 136% upside; FIT +6.5%</a> (June 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363339\" data-linked=\"GoPro +2.6% catching a ride with Fitbit\" data-tweet=\"$GPRO $GPRO $FIT - GoPro +2.6% catching a ride with Fitbit https://seekingalpha.com/news/3363339-goproplus-2_6-catching-ride-fitbit?source=tweet\" data-url=\"https://seekingalpha.com/news/3363339-goproplus-2_6-catching-ride-fitbit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363335\" data-ts=\"1528814869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HERC\" target=\"_blank\">HERC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363335-herc-holdings-rallies-on-m-speculation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herc Holdings rallies on M&amp;A speculation</a></h4><ul> <li>Herc Holdings (<a href='https://seekingalpha.com/symbol/HERC' title='H.E.R.C. Products Inc.'>OTCPK:HERC</a>) <font color='green'>jumps 5.31%</font> after Dealreporter posts an update on potential M&amp;A interest in the equipment rental company.</li> <li>Shares of HRI are up 57% over the last 52 weeks.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3363335\" data-linked=\"Herc Holdings rallies on M&amp;A speculation\" data-tweet=\"$HERC - Herc Holdings rallies on M&amp;A speculation https://seekingalpha.com/news/3363335-herc-holdings-rallies-on-m-speculation?source=tweet\" data-url=\"https://seekingalpha.com/news/3363335-herc-holdings-rallies-on-m-speculation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363332\" data-ts=\"1528814580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKDA\" target=\"_blank\">RKDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363332-arcadia-secures-14m-private-capital-raise-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcadia secures $14M private capital raise; shares down 11%</a></h4><ul><li>Nano cap Arcadia Biosciences (<a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='red'>-11.2%</font>) is down on below-average volume in response to its <a href=\"https://seekingalpha.com/pr/17189602-arcadia-biosciences-announces-14_0-million-registered-direct-offering-priced-market\" target=\"_blank\">direct sale</a> of ~1.4M shares of common stock at $9.93 per share to institutional investors. The company also agreed to sell warrants to the investors to buy up to the same number of shares at $0.125 per warrant. The exercise price is also $9.93.</li><li>Total gross proceeds will be $14M. Net proceeds will be used for general corporate purposes.</li><li>Yesterday's close was $10.02.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363332\" data-linked=\"Arcadia secures $14M private capital raise; shares down 11%\" data-tweet=\"$RKDA - Arcadia secures $14M private capital raise; shares down 11% https://seekingalpha.com/news/3363332-arcadia-secures-14m-private-capital-raise-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3363332-arcadia-secures-14m-private-capital-raise-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363331\" data-ts=\"1528814292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363331-rh-skies-after-margin-improvement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH skies after margin improvement</a></h4><ul> <li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) is <font color='green'>up 29%</font> after posting Q1 results better than anticipated.</li> <li>The retailer is also being backed by Wall Street analysts after showing margin improvement. Deutsche Bank lifts its price target on RH to $160 from $100 as it keeps a Buy rating. Loop Capital and Telsey Advisory Group are also in with PT hikes on the retail stock to $160.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3363114-rh-beats-0_31-misses-revenue\" target=\"_blank\">RH beats by $0.31, misses on revenue</a> (June 11)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3363130-rh-sets-guidance-ahead-expectations\" target=\"_blank\">RH sets guidance ahead of expectations</a> (June 11)</li><li>Sources: MarketBeat.com, Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363331\" data-linked=\"RH skies after margin improvement\" data-tweet=\"$RH - RH skies after margin improvement https://seekingalpha.com/news/3363331-rh-skies-after-margin-improvement?source=tweet\" data-url=\"https://seekingalpha.com/news/3363331-rh-skies-after-margin-improvement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363319\" data-ts=\"1528813574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMG\" target=\"_blank\">KMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363319-kmg-chemicals-up-9-on-q3-results-guidance-raised\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KMG Chemicals up 9% on Q3 results, guidance raised</a></h4><ul><li>KMG Chemicals (<a href='https://seekingalpha.com/symbol/KMG' title='KMG Chemicals, Inc.'>KMG</a> <font color='green'>+9.6%</font>) reported Q3 sales growth of 45.5% Y/Y to $118.6M reflecting strong organic growth in electronic chemicals and performance materials segments, and significant contribution from the acquisition of Flowchem.</li><li>Q3 Overall margins: Gross&nbsp;<font color='green'>improved by 272 bps</font>&nbsp;to 42.56%; operating&nbsp;<font color='green'>improved by 871 bps</font>&nbsp;to 20.2% and Adj. EBITDA margin&nbsp;<font color='green'>improved by 942 bps</font>&nbsp;to 26.5%.</li><li>Electronic chemicals segment: Sales $74.67M (+10% Y/Y), operating margin&nbsp;<font color='green'>improved by 210 bps</font>&nbsp;to 14.6% and Adj. EBITDA increased by 19.7% Y/Y to $13.7M.</li><li>Performance materials segment: Sales $43.98M (+226.4% Y/Y) includes contribution by Flowchem, operating margin&nbsp;<font color='green'>improved by 510 bps</font>&nbsp;to 36.5% and Adj. EBITDA increased by 321% Y/Y to $20.2M.</li><li>Operating cash flow was at $21.5M up 172% Y/Y.</li><li><strong>FY18 Outlook, raised</strong>: Sales $455-465M from $445-455M earlier vs $455.3M consensus; Adj. EBITDA $118-120M from $114-118M; Depreciation &amp; amortization of ~$30M and Capex of ~$25M down from ~$29M earlier.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363116-kmg-chemicals-beats-0_26-beats-revenue\" target=\"_blank\">KMG Chemicals beats by $0.26, beats on revenue</a> (June 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363319\" data-linked=\"KMG Chemicals up 9% on Q3 results, guidance raised\" data-tweet=\"$KMG - KMG Chemicals up 9% on Q3 results, guidance raised https://seekingalpha.com/news/3363319-kmg-chemicals-up-9-on-q3-results-guidance-raised?source=tweet\" data-url=\"https://seekingalpha.com/news/3363319-kmg-chemicals-up-9-on-q3-results-guidance-raised\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363315\" data-ts=\"1528812681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEA\" target=\"_blank\">DTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363315-davids-tea-down-3_9-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DAVIDs TEA down 3.9% post Q1 results</a></h4><ul><li>DAVIDs TEA (<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='red'>-3.9%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4062909\" target=\"_blank\">reports Q1</a> revenue decrease of 5.9% Y/Y to C$45.8M &amp; Comparable sales decreased by&nbsp;7.0%, this overall decline in sales was due to an average decrease in mall traffic and stores located in suboptimal locations.</li><li>E-commerce sales continued to perform well and registered double-digit growth Y/Y.</li><li>Gross profit margin&nbsp;<font color='red'>declined 10 bps</font>&nbsp;to 49.6%, the fall was driven by less promotional activity and a shift in product sales mix, which was offset by a deleveraging of fixed costs due to the negative comparable sales.</li><li>Adj. S, G&amp;A expense decreased 1.6% Y/Y to C$25.2M.</li><li>Adj. EBITDA was C$(0.4)M (-126.7% Y/Y) &amp; Cash of C$53.9M.</li><li>Adjusted results from operating activities was C$(2.4)M (+71.4% Y/Y).</li><li>&ldquo;We have a sharp focus on driving traffic into our stores and to our new online platform, delivering an exceptional customer experience in both. We have a clear plan in place and we are executing on it, but it will take some time to see sustainable results. With the strong management team we now have in place at DAVIDsTEA, I am confident we will get there.&rdquo; said Joel Silver, President &amp; CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363111-davids-tea-eps-line-misses-revenue\" target=\"_blank\">DAVIDs TEA EPS in-line, misses on revenue</a> (June 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363315\" data-linked=\"DAVIDs TEA down 3.9% post Q1 results\" data-tweet=\"$DTEA - DAVIDs TEA down 3.9% post Q1 results https://seekingalpha.com/news/3363315-davids-tea-down-3_9-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3363315-davids-tea-down-3_9-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363318\" data-ts=\"1528812626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAKD\" target=\"_blank\">NAKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363318-naked-brand-group-spikes-after-merger-approved\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Naked Brand Group spikes after merger approved</a></h4><ul> <li>Naked Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a>) is <font color='green'>up 37%</font> after shareholders <a href=\"https://seekingalpha.com/pr/17188856-naked-brand-group-shareholders-approve-merger-agreement-special-meeting\" target=\"_blank\">approved</a>&nbsp;the company's merger agreement with Bendon at a special meeting.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3363318\" data-linked=\"Naked Brand Group spikes after merger approved\" data-tweet=\"$NAKD - Naked Brand Group spikes after merger approved https://seekingalpha.com/news/3363318-naked-brand-group-spikes-after-merger-approved?source=tweet\" data-url=\"https://seekingalpha.com/news/3363318-naked-brand-group-spikes-after-merger-approved\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363307\" data-ts=\"1528811645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363307-pareteum-headed-russell-microcap-index-this-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum headed into Russell Microcap Index this month</a></h4><ul>    <li>Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is <font color='green'>up 6.9%</font> after announcing it's heading into the <a href=\"https://seekingalpha.com/pr/17189519-pareteum-set-join-russell-microcap-index\" target=\"_blank\">Russell Microcap Index</a> in this year's annual reconstitution.</li>    <li>The move is effective after the market opens on June 25.</li>    <li>It's a \"significant milestone\" in the company's history, says Chairman Hal Turner: \"We believe our inclusion will raise awareness across the investment community.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363307\" data-linked=\"Pareteum headed into Russell Microcap Index this month\" data-tweet=\"$TEUM - Pareteum headed into Russell Microcap Index this month https://seekingalpha.com/news/3363307-pareteum-headed-russell-microcap-index-this-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3363307-pareteum-headed-russell-microcap-index-this-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363305\" data-ts=\"1528811517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITI\" target=\"_blank\">ITI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363305-iterisplus-4_5-on-3_2m-contract-award\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iteris +4.5% on $3.2M contract award</a></h4><ul><li>        Iteris (NASDAQ:<a href='https://seekingalpha.com/symbol/ITI' title='Iteris, Inc'>ITI</a>) <a href=\"https://seekingalpha.com/pr/17189411-iteris-awarded-3_2-million-contract-tampa-regional-traffic-management-center\" target=\"_blank\">announces</a> a $3.2M subcontract award to provide operations services and staff to the Florida Department of Transportation traffic management center in Tampa.</li><li>               Under the subcontract with Lucent Group, Iteris will provide services and staff for a minimum of five years.&nbsp;</li><li>               Iteris shares are&nbsp;<font color='green'>up 4.5%</font>&nbsp;to $5.07. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3363305\" data-linked=\"Iteris +4.5% on $3.2M contract award\" data-tweet=\"$ITI - Iteris +4.5% on $3.2M contract award https://seekingalpha.com/news/3363305-iterisplus-4_5-on-3_2m-contract-award?source=tweet\" data-url=\"https://seekingalpha.com/news/3363305-iterisplus-4_5-on-3_2m-contract-award\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363301\" data-ts=\"1528811128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCII\" target=\"_blank\">RCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363301-vintage-capital-makes-new-offer-for-rent-center\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vintage Capital makes new offer for Rent-A-Center</a></h4><ul> <li>Vintage Capital Management submits what it calls its \"best and final offer\" to acquire Rent-A-Center (<a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a> <font color='green'>+8.5%</font>) at $14 per share.</li> <li>The firm says the Rent-A-Center offer is open until 5:00 pm ET on June 15.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3363301\" data-linked=\"Vintage Capital makes new offer for Rent-A-Center\" data-tweet=\"$RCII - Vintage Capital makes new offer for Rent-A-Center https://seekingalpha.com/news/3363301-vintage-capital-makes-new-offer-for-rent-center?source=tweet\" data-url=\"https://seekingalpha.com/news/3363301-vintage-capital-makes-new-offer-for-rent-center\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363300\" data-ts=\"1528811052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363300-frontier-granite-team-on-enhancement-for-multi-location-enterprises-agencies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier, Granite team on enhancement for multi-location enterprises, agencies</a></h4><ul>   <li>Frontier Communications (<a href=\"http://seekingalpha.com/symbol/FTR\" target=\"_blank\">FTR</a> <font color='green'>+1.9%</font>) and Granite Telecommunications <a href=\"https://seekingalpha.com/pr/17189221-frontier-granite-expand-partnership-enhance-services-multi-location-businesses-government\" target=\"_blank\">have a deal</a> to enhance delivery of Next Generation Ethernet to Granite's big multi-location customers.</li>    <li>That will give Granite expanded access to Frontier's 29-state territory and LIT buildings, the two say -- particularly in providing Ethernet to locations of federal agencies under the new Enterprise Infrastructure Solutions contract.</li>    <li>&ldquo;This enhanced relationship with Frontier expands, and further solidifies, Granite&rsquo;s ability to serve multi-location businesses and federal agencies,&rdquo; says Granite's Sam Kline.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363300\" data-linked=\"Frontier, Granite team on enhancement for multi-location enterprises, agencies\" data-tweet=\"$FTR - Frontier, Granite team on enhancement for multi-location enterprises, agencies https://seekingalpha.com/news/3363300-frontier-granite-team-on-enhancement-for-multi-location-enterprises-agencies?source=tweet\" data-url=\"https://seekingalpha.com/news/3363300-frontier-granite-team-on-enhancement-for-multi-location-enterprises-agencies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363287\" data-ts=\"1528810121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JW.A\" target=\"_blank\">JW.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363287-wileyplus-2-amid-heavy-research-revenue-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wiley +2% amid heavy research revenue gains</a></h4><ul>   <li>John Wiley &amp; Sons (NYSE:<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a>) is <font color='green'>up 2%</font> premarket after its <a href=\"https://seekingalpha.com/news/3363242-john-wiley-and-sons-beats-0_15-beats-revenue\" target=\"_blank\">Q4 earnings</a> beat expectations on top and bottom lines.</li>    <li>EPS rose 16% on a GAAP basis and operating income increased 18%. At constant currency, EPS rose 6% and operating income 15%.</li>    <li>Revenue rose 6% on a headline basis, up 1% in constant currency.</li>    <li>Revenue breakout: Research: $258.4M (up 10.2%); Publishing, $151.1M (down 1.7%); Solutions, $67.7M (up 5.9%).</li>    <li>For fiscal 2019, it sees revenues about even with the prior year's $1.796B; adjusted EPS declining in mid-single digits from $3.43; operating cash flow declining in the high single digits rfrom $373.8M; and capex modestly lower from $149.9M.</li>    <li><a href=\"https://www.wiley.com/en-us/investors\" target=\"_blank\">Conference call</a> to come at 10 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17189248-wiley-reports-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3363287\" data-linked=\"Wiley +2% amid heavy research revenue gains\" data-tweet=\"$JW.A $JW.B - Wiley +2% amid heavy research revenue gains https://seekingalpha.com/news/3363287-wileyplus-2-amid-heavy-research-revenue-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3363287-wileyplus-2-amid-heavy-research-revenue-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363285\" data-ts=\"1528809947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLMD\" target=\"_blank\">GLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363285-premarket-gainers-of-9-05-06-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (06/12/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+200%</font>&nbsp;on mid-stage <a href=\"https://seekingalpha.com/news/3363226-galmed-release-mid-stage-data-nash-candidate-aramchol-morning-shares-60-percent-premarket\" target=\"_blank\">data</a> on NASH candidate Aramchol.</li>     <li><a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+45%</font>&nbsp;on merger <a href=\"https://seekingalpha.com/pr/17188856-naked-brand-group-shareholders-approve-merger-agreement-special-meeting\" target=\"_blank\">agreement</a>.</li>     <li><a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='green'>+21%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3363114-rh-beats-0_31-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='green'>+21%</font>&nbsp;on first <a href=\"https://seekingalpha.com/pr/17188947-foresight-announces-first-sale-quadsighttm-prototype\" target=\"_blank\">sale</a> of QuadSight.</li>     <li><a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a> <font color='green'>+21%</font>&nbsp;on purchase agreement and interconnection <a href=\"https://seekingalpha.com/pr/17189378-vivopower-international-plc-announces-signed-ppa-interconnection-south-carolina-solar-project\" target=\"_blank\">agreement</a>.</li>     <li><a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a> <font color='green'>+14%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3363211-lands-end-beats-0_09-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a> <font color='green'>+14%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3363112-dave-and-busters-beats-0_11-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='green'>+13%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17189540-kandi-pure-electric-vehicle-product-pursuing-expansion-american-market\" target=\"_blank\">expansion</a> into American market.</li>     <li><a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3363278-moleculin-bio-10-percent-premarket-development-wp1732-ocular-tumors\" target=\"_blank\">development</a> of WP1732 for ocular tumors.</li>     <li><a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a> <font color='green'>+9%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a> <font color='green'>+8%</font>&nbsp;as&nbsp;PLX-PAD cells <a href=\"https://seekingalpha.com/news/3363231-pluristems-plx-pad-cells-successful-mid-stage-ic-study-shares-ahead-14-percent-premarket\" target=\"_blank\">successful</a> in mid-stage IC study.</li>     <li><a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color='green'>+6%</font>&nbsp;as accelerated <a href=\"https://seekingalpha.com/news/3363220-sage-therapeutics-implement-accelerated-development-plan-antidepressant-sageminus-217\" target=\"_blank\">development</a> plan for antidepressant SAGE-217.</li>     <li><a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='green'>+6%</font>&nbsp;on share offering, convertible note <a href=\"https://seekingalpha.com/news/3363179-intelsat-prices-share-offering-convertible-note-offering\" target=\"_blank\">offering</a>.</li>     <li><a href='https://seekingalpha.com/symbol/HMI' title='Huami Corporation'>HMI</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363285\" data-linked=\"Premarket Gainers as of 9:05 am (06/12/2018)\" data-tweet=\"$GLMD $GLMD $NAKD - Premarket Gainers as of 9:05 am (06/12/2018) https://seekingalpha.com/news/3363285-premarket-gainers-of-9-05-06-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363285-premarket-gainers-of-9-05-06-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363284\" data-ts=\"1528809588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFFN\" target=\"_blank\">DFFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363284-diffusion-pharma-up-14-premarket-on-european-patent-for-oral-tsc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diffusion Pharma up 14% premarket on European patent for oral TSC</a></h4><ul><li>Thinly traded nano cap Diffusion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a>) is up&nbsp;<font color='green'>14%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/17189415-diffusion-pharmaceuticals-announces-validation-european-patent-oral-formulations-tsc\" target=\"_blank\">announcement </a>of a European patent covering oral formulations of bipolar trans carotenoids, including lead drug trans sodium crocetinate &#40;TSC&#41;. The claims also include compositions for the treatment of hypoxia caused by a range of disorders.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3327353-diffusion-pharma-awarded-two-u-s-patents-covering-lead-candidate-tsc-shares-10-percent\" target=\"_blank\">Diffusion Pharma awarded two U.S. patents covering lead candidate TSC; shares up 10%</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363284\" data-linked=\"Diffusion Pharma up 14% premarket on European patent for oral TSC\" data-tweet=\"$DFFN - Diffusion Pharma up 14% premarket on European patent for oral TSC https://seekingalpha.com/news/3363284-diffusion-pharma-up-14-premarket-on-european-patent-for-oral-tsc?source=tweet\" data-url=\"https://seekingalpha.com/news/3363284-diffusion-pharma-up-14-premarket-on-european-patent-for-oral-tsc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363279\" data-ts=\"1528809221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDRA\" target=\"_blank\">IDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363279-premarket-losers-of-9-05-6-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (6/12/2018)</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>&nbsp;<font color='red'>-14%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3363260-idera-pharmas-imominus-8400-flunks-mid-stage-dermatomyositis-study-shares-13-percent\" target=\"_blank\">after</a> IMO-8400 flunks mid-stage dermatomyositis study.</li><li><a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/JCAP' title='Jernigan Capital'>JCAP</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3363155-jernigan-capital-takes-5-percent-hit-starting-3_5m-share-stock-offering\" target=\"_blank\">commencing</a> public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a>&nbsp;<font color='red'>-7%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3363257-microvision-minus-2_3-percent-pricing-secondary-offering\" target=\"_blank\">pricing</a> secondary offering.</li><li><a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17189602-arcadia-biosciences-announces-14_0-million-registered-direct-offering-priced-market\" target=\"_blank\">announcing</a> $14M registered direct offering priced at-the-market.</li><li><a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363279\" data-linked=\"Premarket Losers as of 9:05 am (6/12/2018)\" data-tweet=\"$IDRA $IDRA $NNDM - Premarket Losers as of 9:05 am (6/12/2018) https://seekingalpha.com/news/3363279-premarket-losers-of-9-05-6-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3363279-premarket-losers-of-9-05-6-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363278\" data-ts=\"1528809208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363278-moleculin-bio-up-10-premarket-on-development-of-wp1732-for-ocular-tumors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin Bio up 10% premarket on development of WP1732 for ocular tumors</a></h4><ul><li>Thinly traded nano cap Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/17189181-moleculin-targets-accelerated-fda-approval-wp1732-pursues-development-ocular-tumors\" target=\"_blank\">announced agreement </a>with a Polish University aimed at developing STAT3 inhibitor WP1732 for ocular tumors, a Orphan Drug indication that should qualify for accelerated review in the U.S. and elsewhere.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363278\" data-linked=\"Moleculin Bio up 10% premarket on development of WP1732 for ocular tumors\" data-tweet=\"$MBRX - Moleculin Bio up 10% premarket on development of WP1732 for ocular tumors https://seekingalpha.com/news/3363278-moleculin-bio-up-10-premarket-on-development-of-wp1732-for-ocular-tumors?source=tweet\" data-url=\"https://seekingalpha.com/news/3363278-moleculin-bio-up-10-premarket-on-development-of-wp1732-for-ocular-tumors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363276\" data-ts=\"1528808778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALBO\" target=\"_blank\">ALBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363276-albireo-pharma-nabs-rare-pediatric-disease-tag-for-a4250-for-rare-liver-disorder-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Albireo Pharma nabs Rare Pediatric Disease tag for A4250 for rare liver disorder; shares up 7% premarket</a></h4><ul><li>Thinly traded micro cap Albireo Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ALBO' title='Albireo Pharma, Inc.'>ALBO</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17189397-fda-grants-rare-pediatric-disease-designation-a4250-albireo-eligible-apply-priority-review\" target=\"_blank\">announcement </a>that the FDA has granted Rare Pediatric Disease Designation for lead drug A4250 for the treatment of a rare life-threatening liver disease called progressive familial intrahepatic cholestasis &#40;PFIC&#41;, an Orphan Drug indication in the U.S. and Europe.</li><li>If A4250 is approved, the company will receive a Rare Pediatric Disease Priority Review Voucher that it can use for accelerated review for a future marketing application or it can sell it to a third party.</li><li>A4250, an ileal bile acid transporter inhibitor, is currently in Phase 3 development for PFIC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363276\" data-linked=\"Albireo Pharma nabs Rare Pediatric Disease tag for A4250 for rare liver disorder; shares up 7% premarket\" data-tweet=\"$ALBO - Albireo Pharma nabs Rare Pediatric Disease tag for A4250 for rare liver disorder; shares up 7% premarket https://seekingalpha.com/news/3363276-albireo-pharma-nabs-rare-pediatric-disease-tag-for-a4250-for-rare-liver-disorder-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3363276-albireo-pharma-nabs-rare-pediatric-disease-tag-for-a4250-for-rare-liver-disorder-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363265\" data-ts=\"1528807757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIP\" target=\"_blank\">ANIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363265-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>ANI Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a>) initiated with Overweight rating and $85 (28% upside) price target at Cantor Fitzgerald.</li><li>Biohaven Pharmaceutical (NYSE:<a href='https://seekingalpha.com/symbol/BHVN' title='Biohaven Pharmaceutical Holding Company Ltd.'>BHVN</a>) initiated with Overweight rating and $42 (17% upside) price target at Cantor.</li><li>Collegium Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/COLL' title='Collegium Pharmaceutical'>COLL</a>) initiated with Overweight rating and $40 (60% upside) price target at Cantor.</li><li>Emergent BioSolutions (NYSE:<a href='https://seekingalpha.com/symbol/EBS' title='Emergent BioSolutions Inc.'>EBS</a>) initiated with Overweight rating and $62 (17% upside) price target at Cantor.</li><li>Eagle Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EGRX' title='Eagle Pharmaceuticals Inc.'>EGRX</a>) initiated with Overweight rating and $81 (13% upside) price target at Cantor.</li><li>ObsEva (NASDAQ:<a href='https://seekingalpha.com/symbol/OBSV' title='ObsEva'>OBSV</a>) initiated with Outperform rating and $23 (57% upside) price target at BMO Capital Markets.</li><li>Stemline Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/STML' title='Stemline Therapeutics'>STML</a>) initiated with Buy rating and $30 (68% upside) price target at Roth Capital.</li><li>Healthcare Services Group (NASDAQ:<a href='https://seekingalpha.com/symbol/HCSG' title='Healthcare Services Group, Inc.'>HCSG</a>) initiated with Buy rating and $50 (28% upside) price target at The Benchmark Company.</li><li>ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) initiated with Outperform rating and $7 (33% upside) price target at Oppenheimer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363265\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ANIP $ANIP $BHVN - Premarket analyst action - healthcare https://seekingalpha.com/news/3363265-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3363265-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363260\" data-ts=\"1528807004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDRA\" target=\"_blank\">IDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363260-idera-pharmas-imominus-8400-flunks-mid-stage-dermatomyositis-study-shares-down-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Idera Pharma&#39;s IMO-8400 flunks mid-stage dermatomyositis study; shares down 13% premarket</a></h4><ul><li>Idera Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>) is down&nbsp;<font color='red'>13%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17189184-idera-pharmaceuticals-reports-results-phase-2-trial-imominus-8400-dermatomyositis\" target=\"_blank\">announcement </a>that a Phase 2 clinical trial evaluating IMO-8400 in adult patients with <a href=\"https://www.mayoclinic.org/diseases-conditions/dermatomyositis/symptoms-causes/syc-20353188\" target=\"_blank\">dermatomyositis</a>, an autoimmune disorder characterized by muscle weakness and skin rash, failed to achieve the primary endpoint.</li><li>The change from baseline to week 24 in Cutaneous Dermatomyositis Disease Area and Severity Index &#40;CDASI&#41; activity scores in treated patients did not separate sufficiently from the placebo group.</li><li>The company provided no guidance related to the status of the program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363260\" data-linked=\"Idera Pharma&#39;s IMO-8400 flunks mid-stage dermatomyositis study; shares down 13% premarket\" data-tweet=\"$IDRA - Idera Pharma&#39;s IMO-8400 flunks mid-stage dermatomyositis study; shares down 13% premarket https://seekingalpha.com/news/3363260-idera-pharmas-imominus-8400-flunks-mid-stage-dermatomyositis-study-shares-down-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3363260-idera-pharmas-imominus-8400-flunks-mid-stage-dermatomyositis-study-shares-down-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363257\" data-ts=\"1528806747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MVIS\" target=\"_blank\">MVIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363257-microvisionminus-2_3-after-pricing-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MicroVision -2.3% after pricing secondary offering</a></h4><ul><li>        MicroVision (NASDAQ:<a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a>) <a href=\"https://seekingalpha.com/pr/17189384-microvision-prices-18-million-offering-common-stock\" target=\"_blank\">prices</a> its public offering of 14.4M shares at $1.25/share for gross proceeds of about $18M.</li><li>               Initial purchasers will have the option to buy an added 2.16M shares. &nbsp;&nbsp;</li><li>               MicroVision expects to receive net proceeds of approximately $16.7M from the offering, which should close on Thursday.&nbsp;</li><li>               MicroVision shares are&nbsp;<font color='red'>down 2.3%</font>&nbsp;premarket to $1.26.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363175-microvision-minus-1_6-percent-secondary-offering\" target=\"_blank\">MicroVision -1.6% on secondary offering</a> (June 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3363257\" data-linked=\"MicroVision -2.3% after pricing secondary offering\" data-tweet=\"$MVIS - MicroVision -2.3% after pricing secondary offering https://seekingalpha.com/news/3363257-microvisionminus-2_3-after-pricing-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3363257-microvisionminus-2_3-after-pricing-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363251\" data-ts=\"1528805928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363251-cleveland-cliffs-to-sell-australian-iron-ore-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland-Cliffs to sell Australian iron ore assets</a></h4><ul>     <li>Cleveland-Cliffs (NYSE:<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a>)&nbsp;<font color='green'>+1.8%</font> premarket after <a href=\"https://seekingalpha.com/pr/17189113-cleveland-cliffs-inc-agrees-sell-iron-ore-assets-australia\" target=\"_blank\">agreeing to sell</a> its Asia Pacific Iron Ore business to Australian mining services company Mineral Resources for an undisclosed sum.</li>     <li>CLF expects previously disclosed costs of closing the Australian operations will be reduced by $65M-$75M.</li>     <li>CLF says the sale marks the company's exit from the Australian iron ore business and is \"the final step in the implementation of our U.S. iron ore-centric strategy.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363251\" data-linked=\"Cleveland-Cliffs to sell Australian iron ore assets\" data-tweet=\"$CLF - Cleveland-Cliffs to sell Australian iron ore assets https://seekingalpha.com/news/3363251-cleveland-cliffs-to-sell-australian-iron-ore-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3363251-cleveland-cliffs-to-sell-australian-iron-ore-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363250\" data-ts=\"1528805732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTW\" target=\"_blank\">WTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363250-jpmorgan-bullish-on-weight-watchers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan bullish on Weight Watchers</a></h4><ul> <li>JPMorgan starts off coverage on Weight Watchers (NYSE:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>) with an <a href=\"https://www.cnbc.com/2018/06/12/stocks-making-the-biggest-moves-premarket-t-twx-rh-play-xom-tsla-c-more.html\" target=\"_blank\">Overweight rating</a> on a positive view of the company's revenue growth through the digital program.</li> <li>Analyst Christina Brathwaite also sees +20% earnings growth potential for Weight Watchers on the bottom line.</li> <li>Shares of Weight Watchers are <font color='green'>up 3.05%</font> in premarket trading.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3363250\" data-linked=\"JPMorgan bullish on Weight Watchers\" data-tweet=\"$WTW $WW - JPMorgan bullish on Weight Watchers https://seekingalpha.com/news/3363250-jpmorgan-bullish-on-weight-watchers?source=tweet\" data-url=\"https://seekingalpha.com/news/3363250-jpmorgan-bullish-on-weight-watchers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363243\" data-ts=\"1528805020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363243-keybanc-lifts-model-3-deliveries-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc lifts Model 3 deliveries estimates</a></h4><ul> <li>KeyBanc Capital Markets lifts its forecast for Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) Model 3 deliveries in Q2 to 30K from 20K after conducting <a href=\"https://www.cnbc.com/2018/06/12/tesla-shares-rise-after-analyst-raises-model-3-delivery-estimate-by-50-percent.html\" target=\"_blank\">channel checks</a> at 20 Tesla stores.</li> <li>\"Our checks with sales centers indicate Model 3 deliveries are tracking ~50% higher than our prior estimates for the quarter, prompting us to raise our estimates,\" advises KeyBanc analyst Brad Erickson.</li> <li>KeyBanc expects full-year Model 3 deliveries of 118,182 units vs. 98,182 units prior estimate.</li> <li>KeyBanc has a $300 fair value price target on Tesla based on the \"significant premium\" already built into the share price.</li> <li>Shares of Tesla are <font color='green'>up 2.60%</font> in premarket trading to $340.75.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363243\" data-linked=\"KeyBanc lifts Model 3 deliveries estimates\" data-tweet=\"$TSLA - KeyBanc lifts Model 3 deliveries estimates https://seekingalpha.com/news/3363243-keybanc-lifts-model-3-deliveries-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3363243-keybanc-lifts-model-3-deliveries-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>138&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363231\" data-ts=\"1528803459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363231-pluristems-plx-pad-cells-successful-in-mid-stage-ic-study-shares-ahead-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem&#39;s PLX-PAD cells successful in mid-stage IC study; shares ahead 14% premarket</a></h4><ul><li>Pluristem Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a>) is up&nbsp;<font color='green'>14%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/17189040-pluristem-reports-positive-top-line-results-multinational-phase-ii-intermittent-claudication\" target=\"_blank\">announcement </a>of positive results from a Phase 2 clinical trial assessing its PLX-PAD cells in patients with a type of peripheral arterial disease called intermittent claudication &#40;IC&#41;.</li><li>The study met the primary endpoint of a statistically valid change from baseline in maximal walking distance at week 52 versus placebo.</li><li>Patients in the treatment group experienced 49% less risk of revascularization (hazard ratio = 0.51). Also, intramuscular administration of PLX-PAD was safe and well-tolerated.</li><li>A pivotal<a href=\"https://clinicaltrials.gov/ct2/show/NCT03006770?spons=pluristem&amp;phase=12&amp;rank=2\" target=\"_blank\"> Phase 3 study</a> in critical limb ischemia is ongoing. According to ClinicalTrials.gov, the estimated completion date is May 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363231\" data-linked=\"Pluristem&#39;s PLX-PAD cells successful in mid-stage IC study; shares ahead 14% premarket\" data-tweet=\"$PSTI - Pluristem&#39;s PLX-PAD cells successful in mid-stage IC study; shares ahead 14% premarket https://seekingalpha.com/news/3363231-pluristems-plx-pad-cells-successful-in-mid-stage-ic-study-shares-ahead-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3363231-pluristems-plx-pad-cells-successful-in-mid-stage-ic-study-shares-ahead-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363229\" data-ts=\"1528803145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIA\" target=\"_blank\">ACIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363229-acacia-communicationsplus-1_1-on-zte-statement-reaffirmed-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acacia Communications +1.1% on ZTE statement, reaffirmed guidance</a></h4><ul><li>        Acacia Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a>) <a href=\"https://seekingalpha.com/pr/17189137-acacia-communications-provides-update-u-s-department-commerce-settlement-zte\" target=\"_blank\">says</a> it won&rsquo;t resume its relationship with ZTE until the U.S. Department of Commerce removes the company from the Denied Persons List.</li><li>               Acacia reaffirms its Q2 guidance <a href=\"https://seekingalpha.com/pr/17152204-acacia-communications-reports-first-quarter-2018-results\" target=\"_blank\">provided in May</a>, which had revenue from $60M to $66M and EPS from -$0.15 to -$0.03.&nbsp;</li><li>               The statement follows a report that the Senate is pushing back against the White House deal to revive ZTE.&nbsp;</li><li>               Acacia shares are&nbsp;<font color='green'>up 1.1%</font>&nbsp;premarket to $35.09. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3363229\" data-linked=\"Acacia Communications +1.1% on ZTE statement, reaffirmed guidance\" data-tweet=\"$ACIA - Acacia Communications +1.1% on ZTE statement, reaffirmed guidance https://seekingalpha.com/news/3363229-acacia-communicationsplus-1_1-on-zte-statement-reaffirmed-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3363229-acacia-communicationsplus-1_1-on-zte-statement-reaffirmed-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363226\" data-ts=\"1528802685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLMD\" target=\"_blank\">GLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363226-galmed-to-release-mid-stage-data-on-nash-candidate-aramchol-this-morning-shares-up-60\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galmed to release mid-stage data on NASH candidate Aramchol this morning; shares up 60% premarket</a></h4><ul><li>Thinly traded micro cap Galmed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a>) is up&nbsp;<font color='green'>60%</font>&nbsp;premarket on light volume ahead of its 8:00 am ET<a href=\"https://seekingalpha.com/pr/17188774-galmed-pharmaceuticals-host-conference-call-discuss-top-line-52-week-results-global-phase-2b\" target=\"_blank\"> conference call</a> to discuss topline results from its Phase 2b ARREST study assessing Aramchol (arachidyl amido cholanoic acid) in nonalcoholic steatohepatitis &#40;NASH&#41;.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330944-galmeds-aramchol-flunks-mid-stage-nafld-study\" target=\"_blank\">Galmed's Aramchol flunks mid-stage NAFLD study</a> (Feb. 14)</li><li><strong>Update</strong>: The company says 400 mg of Aramchol demonstrated a statistically significant reduction in liver fat versus placebo as determined by magnetic resonance spectroscopy &#40;MRS&#41;. Significantly more patients receiving 600 mg of Aramchol experienced NASH resolution without worsening fibrosis, a <a href=\"https://seekingalpha.com/pr/17189157-galmeds-600-mg-aramchol-achieved-regulatory-approvable-endpoint-showing-nash-resolution\" target=\"_blank\">regulatory approvable endpoint</a>. Also, a higher proportion of patients treated with the 600 mg dose experienced at least a one-point improvement in fibrosis score without worsening of NASH, another regulatory approvable endpoint. Statistically significant reductions in liver enzymes ALT and AST were observed in both dose cohorts compared to placebo. The safety profile was favorable. Shares are up&nbsp;<font color='green'>170%</font>&nbsp;premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3363226\" data-linked=\"Galmed to release mid-stage data on NASH candidate Aramchol this morning; shares up 60% premarket\" data-tweet=\"$GLMD - Galmed to release mid-stage data on NASH candidate Aramchol this morning; shares up 60% premarket https://seekingalpha.com/news/3363226-galmed-to-release-mid-stage-data-on-nash-candidate-aramchol-this-morning-shares-up-60?source=tweet\" data-url=\"https://seekingalpha.com/news/3363226-galmed-to-release-mid-stage-data-on-nash-candidate-aramchol-this-morning-shares-up-60\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363221\" data-ts=\"1528802370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363221-twitterplus-2_3-jp-morgan-sees-21-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter +2.3% as JP Morgan sees 21% upside</a></h4><ul><li>        JP Morgan <a href=\"https://www.streetinsider.com/Analyst+Comments/Twitter%2C+Inc.+%28TWTR%29+PT+Raised+to+%2450+at+JPMorgan%2C+Remains+a+Top+Pick+and+on+Analyst+Focus+List/14296414.html\" target=\"_blank\">raises</a> its Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) price target from $39 to $50, a 21% upside to yesterday&rsquo;s close.</li><li>               Rating maintained at Overweight.&nbsp;</li><li>               Twitter shares are&nbsp;<font color='green'>up 2.3%</font>&nbsp;premarket to $42.36. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3363221\" data-linked=\"Twitter +2.3% as JP Morgan sees 21% upside\" data-tweet=\"$TWTR - Twitter +2.3% as JP Morgan sees 21% upside https://seekingalpha.com/news/3363221-twitterplus-2_3-jp-morgan-sees-21-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3363221-twitterplus-2_3-jp-morgan-sees-21-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363219\" data-ts=\"1528802103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGUIF\" target=\"_blank\">CGUIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363219-casino-guichard-perrachon-updates-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casino Guichard-Perrachon updates targets</a></h4><ul> <li>Casino Guichard-Perrachon (<a href='https://seekingalpha.com/symbol/CGUIF' title='Casino Guichard Perrachon SA'>OTCPK:CGUIF</a>, <a href='https://seekingalpha.com/symbol/CGUSY' title='Casino Guichard Perrachon SA ADR'>OTCPK:CGUSY</a>) agrees to sell non-core assets worth about $1.77B during this year and the first part of 2019.</li> <li>The company has set a goal to top its prior profit growth targets in France and meet its debt-reduction targets.</li> <li>\"Good operational performance has been achieved to date in France where the Group expects like-for-like sales growth in Q2 (excluding calendar effects) to be higher than in Q1,\" reads an update from Casino.</li> <li><a href=\"https://www.groupe-casino.fr/en/wp-content/uploads/sites/2/2018/06/2018-11-06-VA-Asset-disposal-plan-1106-17H.pdf\" target=\"_blank\">Casino Group press release</a> (.pdf)</li> <li>Casino Guichard is <font color='green'>up 2.65%</font> in Paris trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363219\" data-linked=\"Casino Guichard-Perrachon updates targets\" data-tweet=\"$CGUIF $CGUIF $CGUSY - Casino Guichard-Perrachon updates targets https://seekingalpha.com/news/3363219-casino-guichard-perrachon-updates-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3363219-casino-guichard-perrachon-updates-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3363216\" data-ts=\"1528801619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LE\" target=\"_blank\">LE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3363216-lands-endplus-6-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lands&#39; End +6% after earnings topper</a></h4><ul> <li>Shares of Lands' End (NASDAQ:<a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a>) jump in premarket action after the retailer narrowed its <a href=\"https://seekingalpha.com/pr/17189077-lands-end-announces-first-quarter-fiscal-2018-results\" target=\"_blank\">FQ1 loss</a>.</li> <li>Adjusted EBITA improved to $9M from $1.3M, despite a sharp drop in same-store sales due to fewer Lands' End Shops at Sears.</li> <li>Gross margin fell 130 bps to 44.4% of sales.</li> <li>CEO update: \"Our first quarter results represent the fourth straight quarter of top line growth and third quarter of profitability growth, demonstrating the continued progress we have made across our strategic initiatives. We saw excellent growth in our uniform business with the successful launch of our Delta Airline business.\"</li> <li>Lands' End ended the quarter with cash of $142M and long-term debt of $485M.</li> <li>Lands' End is <font color='green'>up 6.38%</font> on light premarket volume after gaining 6.58% yesterday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363211-lands-end-beats-0_09-beats-revenue\" target=\"_blank\">Lands' End beats by $0.09, beats on revenue</a> (June 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3363216\" data-linked=\"Lands&#39; End +6% after earnings topper\" data-tweet=\"$LE - Lands&#39; End +6% after earnings topper https://seekingalpha.com/news/3363216-lands-endplus-6-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3363216-lands-endplus-6-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM </div></div></li>","count":70,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}